“Targeting peptide” discovery offers ... - Lung Conditions C...

Lung Conditions Community Forum

55,061 members65,847 posts

“Targeting peptide” discovery offers hope as new, highly effective anti-inflammatory

2greys profile image
2 Replies

A collaboration between the University of Toronto’s Faculty of Dentistry and the National Jewish Hospital in Denver —the top-ranked respirology research hospital in the U.S. — has yielded a new discovery that could be useful to combat inflammation of all varieties and shows promise in fighting acute respiratory illnesses such as COVID-19.

Called TAT CARMIL1, the discovery is a combination of two naturally occurring peptides that, when combined, work together to penetrate a cell’s membrane in order to dampen an acute inflammatory response.

In this first ex vivo study, the peptide reduced collagen degradation by up to 43 per cent. If deployed early enough, the researchers say, the peptide could allay some of the worst damage caused by acute inflammatory responses.

dentistry.utoronto.ca/news/...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
2 Replies
RoadRunner44 profile image
RoadRunner44

👍👍👍

Patk1 profile image
Patk1

This could be fantastic - certainly what i need! Thanx 4 this 2greys x

You may also like...

New and Saying Hello after COVID

into my lungs than breathlessness. During the acute infection, I didn't end up going into the...

PIP when on oxygen 24/7

and E. After a couple of days and nights in The Acute Medical Unit and receiving around the clock...

Study finds over 80 percent of COVID-19 patients have vitamin D deficiency.

linked to a variety of health concerns, although research is still underway into why the hormone...

Organising pneumonia - how soon do the steroids kick in?

autoimmune conditions. My symptoms were never so acute that I could not maintain my usual daily...

1st hospital respirtitatry appointment cancelled